European Alliance for
Newborn Screening in Spinal Muscular Atrophy
Opening a new horizon
for children born with spinal muscular atrophy
SMA: Screen at birth, save lives
Identifying children living with SMA through NBS allows for treatment to be started on time, preventing motor neuron death and a life with severe disability or even death.
Today, June 28 2002 is International Neonatal Screening Day (INSD) “International Neonatal Screening Day (INSD) is an international initiative launched by the International Society for Neonatal Screening (ISNS), the International Patient Organisation for Primary Immunodeficiencies (IPOPI) and the European Society for Immunodeficiencies (ESID), working in partnership under the multi-stakeholder Screen4Rare platform to promote the importance of […]
The AFM-Téléthon, the University Hospitals of Strasbourg, and the Center Hospitalier Universitaire de Bordeaux are launching a pilot project called DEPISMA for neonatal genetic screening for spinal muscular atrophy (SMA) in the Grand-Est and in Nouvelle-Aquitaine regions of France, in collaboration with the regional health agencies. The first babies to be screened for SMA will be […]
We are proud to announce that SMA Europe has officially joined the Screen4Rare platform as a Partner! After endorsing the Screen4Rare Call to Action – Newborn Screening for Rare Diseases, SMA Europe has become part of the Screen4Rare platform. We plan to take part in the MEP Interest Group and the upcoming International Newborn Screening […]
The European Alliance for Newborn Screening in Spinal Muscular Atrophy demands that by 2025, newborn screening programmes in all European countries include a test for spinal muscular atrophy for all newborn children.